European Union · Record · QUESTION_WRITTEN_PRIORITY
P-9-2020-003851
Access to clinical trial information and transparency in the vaccine strategy
Introduced
30 June 2020
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
28 October 2020
Official titles
Authentic titles published by the source. The stored canonical title is not replaced.
5 official languages
Danish
Adgang til information om kliniske forsøg og gennemsigtighed i vaccinestrategien
German
Zugang zu Informationen über klinische Studien und Transparenz in der Impfstoffstrategie
Finnish
Oikeus tutustua kliiniseen lääketutkimukseen ja rokotestrategian avoimuus
French
Accès aux informations issues d’essais cliniques et transparence dans la stratégie de vaccination
Swedish
Tillgång till information om kliniska prövningar och transparens i vaccinstrategin
Records
Official record P-9-2020-003851 from European Union at European Parliament. Dated 30 June 2020. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
20 official files
Access to clinical trial information and transparency in the vaccine strategy
Access to clinical trial information and transparency in the vaccine strategy
QUESTION_WRITTEN_PRIORITY · EN · 7 July 2020
Access to clinical trial information and transparency in the vaccine strategy
QUESTION_WRITTEN_PRIORITY · EN · 7 July 2020
Access to clinical trial information and transparency in the vaccine strategy
QUESTION_WRITTEN_PRIORITY · EN · 7 July 2020
Answer
QUESTION_WRITTEN_ANSWER
Answer
QUESTION_WRITTEN_ANSWER · 28 October 2020
Tillgång till information om kliniska prövningar och transparens i vaccinstrategin
QUESTION_WRITTEN_PRIORITY · SV · 7 July 2020
Tillgång till information om kliniska prövningar och transparens i vaccinstrategin
QUESTION_WRITTEN_PRIORITY · SV · 7 July 2020
Tillgång till information om kliniska prövningar och transparens i vaccinstrategin
QUESTION_WRITTEN_PRIORITY · SV · 7 July 2020
Accès aux informations issues d’essais cliniques et transparence dans la stratégie de vaccination
QUESTION_WRITTEN_PRIORITY · FR · 7 July 2020
Accès aux informations issues d’essais cliniques et transparence dans la stratégie de vaccination
QUESTION_WRITTEN_PRIORITY · FR · 7 July 2020
Accès aux informations issues d’essais cliniques et transparence dans la stratégie de vaccination
QUESTION_WRITTEN_PRIORITY · FR · 7 July 2020
Oikeus tutustua kliiniseen lääketutkimukseen ja rokotestrategian avoimuus
QUESTION_WRITTEN_PRIORITY · FI · 7 July 2020
Oikeus tutustua kliiniseen lääketutkimukseen ja rokotestrategian avoimuus
QUESTION_WRITTEN_PRIORITY · FI · 7 July 2020
Oikeus tutustua kliiniseen lääketutkimukseen ja rokotestrategian avoimuus
QUESTION_WRITTEN_PRIORITY · FI · 7 July 2020
Zugang zu Informationen über klinische Studien und Transparenz in der Impfstoffstrategie
QUESTION_WRITTEN_PRIORITY · DE · 7 July 2020
Zugang zu Informationen über klinische Studien und Transparenz in der Impfstoffstrategie
QUESTION_WRITTEN_PRIORITY · DE · 7 July 2020
Zugang zu Informationen über klinische Studien und Transparenz in der Impfstoffstrategie
QUESTION_WRITTEN_PRIORITY · DE · 7 July 2020
Adgang til information om kliniske forsøg og gennemsigtighed i vaccinestrategien
QUESTION_WRITTEN_PRIORITY · DA · 7 July 2020
Adgang til information om kliniske forsøg og gennemsigtighed i vaccinestrategien
QUESTION_WRITTEN_PRIORITY · DA · 7 July 2020
Adgang til information om kliniske forsøg og gennemsigtighed i vaccinestrategien
QUESTION_WRITTEN_PRIORITY · DA · 7 July 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.